We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · January 24, 2022

Dexamethasone Implant Responses Predict Fluocinolone Acetonide Intravitreal Implant Outcomes

Eye (London, England)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Eye (London, England)
The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
Eye (Lond) 2021 Dec 01;35(12)3232-3242, MV Cicinelli, A Rosenblatt, D Grosso, P Zollet, L Capone, A Rabiolo, R Lattanzio, A Loewenstein, F Bandello

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading